Long-term Follow-up After Anti-reflux Surgery in Patients with Barrett's Esophagus

Journal of Gastrointestinal Surgery

Volumn 14, Issue 10, 2010, Pages 1483-1491

  Zehetner, Joerg ^a   DeMeester, Steven R ^a,b   Ayazi, Shahin ^a   Costales, Jesse L ^a   Augustin, Florian ^a   Oezcelik, Arzu ^a   Lipham, John C ^a   Sohn, Helen J ^a   Hagen, Jeffrey A ^a   DeMeester, Tom R ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b NONE   (United States)

Author keywords

Anti reflux surgery; Barrett's esophagus; Long term follow up

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; DISEASE COURSE; ESOPHAGUS TUMOR; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; RETROSPECTIVE STUDY; STOMACH FUNDOPLICATION; TIME;

ADENOCARCINOMA; ADULT; AGED; BARRETT ESOPHAGUS; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; FUNDOPLICATION; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 77957020874     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-010-1322-8     Document Type: Article

References (30)

1. Pohl H, Welch HG: The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 2005, 97(2): 142-146.
2. Wani S, Puli SR, Shaheen NJ, Westhoff B, Slehria S, Bansal A, Rastogi A, Sayana H, Sharma P: Esophageal adenocarcinoma in Barrett's esophagus after endoscopic ablative therapy: a meta-analysis and systematic review. Am J Gastroenterol 2009, 104(2): 502-513.
3. Sikkema M, de Jonge PJ, Steyerberg EW, Kuipers EJ: Risk of esophageal adenocarcinoma and mortality in patients with Barrett's esophagus: a systematic review and meta-analysis. Clin Gastroenterol Hepatol, 8(3): 235-244; quiz e232.
4. Ye W, Chow WH, Lagergren J, Yin L, Nyren O: Risk of adenocarcinomas of the esophagus and gastric cardia in patients with gastroesophageal reflux diseases and after antireflux surgery. Gastroenterology 2001, 121(6): 1286-1293.
5. Zaninotto G, DeMeester TR, Schwizer W, Johansson KE, Cheng SC: The lower esophageal sphincter in health and disease. Am J Surg 1988, 155(1): 104-111.
6. Ayazi S, Lipham JC, Portale G, Peyre CG, Streets CG, Leers JM, Demeester SR, Banki F, Chan LS, Hagen JA et al: Bravo catheter-free pH monitoring: normal values, concordance, optimal diagnostic thresholds, and accuracy. Clin Gastroenterol Hepatol 2009, 7(1): 60-67.
7. Barrett NR: The lower esophagus lined by columnar epithelium. Surgery 1957, 41(6): 881-894.
8. Somerville M, Garside R, Pitt M, Stein K: Surveillance of Barrett's oesophagus: is it worthwhile?Eur J Cancer 2008, 44(4): 588-599.
9. Sharma P, Sidorenko EI: Are screening and surveillance for Barrett's oesophagus really worthwhile?Gut 2005, 54 Suppl 1: i27-i32.
10. Inadomi JM, Sampliner R, Lagergren J, Lieberman D, Fendrick AM, Vakil N: Screening and surveillance for Barrett esophagus in high-risk groups: a cost-utility analysis. Ann Intern Med 2003, 138(3): 176-186.
11. Das A, Wells C, Kim HJ, Fleischer DE, Crowell MD, Sharma VK: An economic analysis of endoscopic ablative therapy for management of nondysplastic Barrett's esophagus. Endoscopy 2009, 41(5): 400-408.
12. Mainie I, Tutuian R, Castell DO: Addition of a H2 receptor antagonist to PPI improves acid control and decreases nocturnal acid breakthrough. J Clin Gastroenterol 2008, 42(6): 676-679.
13. Vela MF, Camacho-Lobato L, Srinivasan R, Tutuian R, Katz PO, Castell DO: Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole. Gastroenterology 2001, 120(7): 1599-1606.
14. Schweitzer EJ, Bass BL, Batzri S, Harmon JW: Bile acid accumulation by rabbit esophageal mucosa. Dig Dis Sci 1986, 31(10): 1105-1113.
15. Armstrong D, Rytina ER, Murphy GM, Dowling RH: Gastric mucosal toxicity of duodenal juice constituents in the rat. Acute studies using ex vivo rat gastric chamber model. Dig Dis Sci 1994, 39(2): 327-339.
16. Chiu PW, Ayazi S, Hagen JA, Lipham JC, Zehetner J, Abate E, Oezcelik A, Hsieh CC, DeMeester SR, Banki F et al: Esophageal pH exposure and epithelial cell differentiation. Dis Esophagus 2009, 22(7): 596-599.
17. DeMeester TR, Peters JH, Bremner CG, Chandrasoma P: Biology of gastroesophageal reflux disease: pathophysiology relating to medical and surgical treatment. Annu Rev Med 1999, 50: 469-506.
18. Theisen J, Peters JH, Fein M, Hughes M, Hagen JA, Demeester SR, Demeester TR, Laird PW: The mutagenic potential of duodenoesophageal reflux. Ann Surg 2005, 241(1): 63-68.
19. Kauer WK, Peters JH, DeMeester TR, Ireland AP, Bremner CG, Hagen JA: Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juice alone. The need for surgical therapy re-emphasized. Ann Surg 1995, 222(4): 525-531; discussion 531-523.
20. Oh DS, DeMeester SR, Vallbohmer D, Mori R, Kuramochi H, Hagen JA, Lipham J, Danenberg KD, Danenberg PV, Chandrasoma P et al: Reduction of interleukin 8 gene expression in reflux esophagitis and Barrett's esophagus with antireflux surgery. Arch Surg 2007, 142(6): 554-559; discussion 559-560.
21. Vallbohmer D, DeMeester SR, Oh DS, Banki F, Kuramochi H, Shimizu D, Hagen JA, Danenberg KD, Danenberg PV, Chandrasoma PT et al: Antireflux surgery normalizes cyclooxygenase-2 expression in squamous epithelium of the distal esophagus. Am J Gastroenterol 2006, 101(7): 1458-1466.
22. Babar M, Ennis D, Abdel-Latif M, Byrne PJ, Ravi N, Reynolds JV: Differential molecular changes in patients with asymptomatic long-segment Barrett's esophagus treated by antireflux surgery or medical therapy. Am J Surg, 199(2): 137-143.
23. Katz D, Rothstein R, Schned A, Dunn J, Seaver K, Antonioli D: The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus. Am J Gastroenterol 1998, 93(4): 536-541.
24. Oelschlager BK, Barreca M, Chang L, Oleynikov D, Pellegrini CA: Clinical and pathologic response of Barrett's esophagus to laparoscopic antireflux surgery. Ann Surg 2003, 238(4): 458-464; discussion 464-456.
25. Gurski RR, Peters JH, Hagen JA, DeMeester SR, Bremner CG, Chandrasoma PT, DeMeester TR: Barrett's esophagus can and does regress after antireflux surgery: a study of prevalence and predictive features. J Am Coll Surg 2003, 196(5): 706-712; discussion 712-703.
26. Hofstetter WL, Peters JH, DeMeester TR, Hagen JA, DeMeester SR, Crookes PF, Tsai P, Banki F, Bremner CG: Long-term outcome of antireflux surgery in patients with Barrett's esophagus. Ann Surg 2001, 234(4): 532-538; discussion 538-539.
27. Parrilla P, Martinez de Haro LF, Ortiz A, Munitiz V, Molina J, Bermejo J, Canteras M: Long-term results of a randomized prospective study comparing medical and surgical treatment of Barrett's esophagus. Ann Surg 2003, 237(3): 291-298.
28. Lagergren J, Ye W, Lagergren P, Lu Y: The risk of esophageal adenocarcinoma after antireflux surgery. Gastroenterology 2010: in press.
29. DeMeester SR, Peters JH, Demeester TR: Barrett's esophagus. Curr Probl Surg 2001, 38(8): 558-640. 31.
30. Lagergren J, Viklund P: Is esophageal adenocarcinoma occurring late after antireflux surgery due to persistent postoperative reflux?World J Surg 2007, 31(3): 465-469.